KR102367717B1 - Food composition for relieving hangovers and improving a liver and food containing the same - Google Patents
Food composition for relieving hangovers and improving a liver and food containing the same Download PDFInfo
- Publication number
- KR102367717B1 KR102367717B1 KR1020200168648A KR20200168648A KR102367717B1 KR 102367717 B1 KR102367717 B1 KR 102367717B1 KR 1020200168648 A KR1020200168648 A KR 1020200168648A KR 20200168648 A KR20200168648 A KR 20200168648A KR 102367717 B1 KR102367717 B1 KR 102367717B1
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- weight
- food composition
- food
- liver function
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 206010019133 Hangover Diseases 0.000 title claims abstract description 29
- 210000004185 liver Anatomy 0.000 title description 7
- 239000000843 powder Substances 0.000 claims abstract description 70
- 230000003908 liver function Effects 0.000 claims abstract description 28
- 230000036541 health Effects 0.000 claims abstract description 23
- 235000013376 functional food Nutrition 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 17
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 15
- 240000007124 Brassica oleracea Species 0.000 claims abstract description 15
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims abstract description 15
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims abstract description 15
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims abstract description 15
- 241001070941 Castanea Species 0.000 claims abstract description 15
- 235000014036 Castanea Nutrition 0.000 claims abstract description 15
- 229920001353 Dextrin Polymers 0.000 claims abstract description 15
- 239000004375 Dextrin Substances 0.000 claims abstract description 15
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 15
- 240000003768 Solanum lycopersicum Species 0.000 claims abstract description 15
- 239000012141 concentrate Substances 0.000 claims abstract description 15
- 235000019425 dextrin Nutrition 0.000 claims abstract description 15
- 239000006187 pill Substances 0.000 claims abstract description 5
- 235000013361 beverage Nutrition 0.000 claims abstract description 4
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000008187 granular material Substances 0.000 claims abstract description 4
- 239000003826 tablet Substances 0.000 claims abstract description 4
- 235000010804 Maranta arundinacea Nutrition 0.000 claims description 14
- 235000012419 Thalia geniculata Nutrition 0.000 claims description 14
- 244000151018 Maranta arundinacea Species 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 14
- 206010036067 polydipsia Diseases 0.000 abstract description 5
- 230000001476 alcoholic effect Effects 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 235000011158 Prunus mume Nutrition 0.000 abstract 1
- 244000018795 Prunus mume Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 34
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 26
- 244000145580 Thalia geniculata Species 0.000 description 10
- 230000035622 drinking Effects 0.000 description 9
- 230000037406 food intake Effects 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 7
- 238000000354 decomposition reaction Methods 0.000 description 6
- 201000006549 dyspepsia Diseases 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- 238000010298 pulverizing process Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 208000024798 heartburn Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000000599 Lentinula edodes Species 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000005189 cardiac health Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000020727 milk thistle extract Nutrition 0.000 description 1
- 229940096421 milk thistle extract Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 매실농축액, 양배추분말, 토마토분말, 밤분말 칡부리추출분말, 다시마분말, 덱스트린 등을 함유함으로써 음주로 인한 숙취증상을 해소하고 알콜성 손상에 의해 저하된 간기능을 효과적으로 개선할 수 있는 숙취해소 및 간기능 개선용 식품 조성물 및 이를 이용한 건강 기능식품에 관한 것이다.The present invention contains plum concentrate, cabbage powder, tomato powder, chestnut powder, arrowroot extract powder, kelp powder, dextrin, and the like, thereby relieving hangover symptoms caused by drinking and effectively improving liver function lowered by alcoholic damage. It relates to a food composition for relieving a hangover and improving liver function, and a health functional food using the same.
일반적으로, 과다 알콜섭취는 숙취현상을 유발하고 간기능을 저하시키는 것으로 알려져 있다. 간은 우리 몸에서 두 번째로 큰 장기로서, 대표적인 기능으로 해독작용을 하며 물질대사에 주요 역할을 담당한다.In general, it is known that excessive alcohol intake causes a hangover and lowers liver function. The liver is the second largest organ in our body, and its representative function is to detoxify and play a major role in metabolism.
음주로 인해 알콜을 섭취할 경우 혈관을 통해 간으로 이동한 알콜은 알콜탈수효소(alcohol dehydrogenase, ADH)에 의해 아세트알데히드(acetaldehyde)로 전환되고 아세트알데히드는 아세트알데히드 탈수소효소(acetaldehyde dehydrogenase, ALDH)에 의해 아세테이트(acetate)로 전환된 후 최종적으로 이산화탄소와 물로 분해된다.When alcohol is ingested due to drinking, the alcohol that moves through the blood vessels to the liver is converted to acetaldehyde by alcohol dehydrogenase (ADH), which is then converted to acetaldehyde dehydrogenase (ALDH). After being converted to acetate by means of which is finally decomposed into carbon dioxide and water.
과음으로 인한 숙취현상은 상기와 같은 알콜이 이산화탄소와 물로 분해되지 않고 체내에 에탄올(ethanol) 및 아세트알데히드(acetaldehyde)로서 축적됨에 따라 구토, 설사, 어지러움, 갈증, 전신권태, 피로감, 기억상실, 복부팽만감, 소화 불량, 비타민 결핍 등을 유발하는 현상이다.The hangover caused by excessive drinking is caused by the accumulation of alcohol as ethanol and acetaldehyde in the body instead of being decomposed into carbon dioxide and water, so vomiting, diarrhea, dizziness, thirst, general malaise, fatigue, memory loss, abdominal It is a phenomenon that causes bloating, indigestion, and vitamin deficiency.
아세트알데히드 탈수소효소에는 아세트알데히드가 저농도일 때부터 작용하는 Ⅱ형과 아세트알데히드가 고농도로 되어야 작용을 하는 Ⅰ형이 있다. 동양인은 서양인과 비교하여 Ⅱ형 아세트알데히드 탈수소효소가 결핍되어 있거나 부족하므로 아세트알데히드의 분해가 느리다. 따라서 분해되지 않고 체내에 축적된 아세트알데히드에 의해 각종 숙취현상을 더 많이 느끼게 된다.There are two types of acetaldehyde dehydrogenase: type II, which works when acetaldehyde is at a low concentration, and type I, which works when acetaldehyde is at a high concentration. Compared to Westerners, Asians lack or lack type II acetaldehyde dehydrogenase, so the decomposition of acetaldehyde is slow. Therefore, various hangover phenomena are felt more by acetaldehyde accumulated in the body without being decomposed.
또한, 알콜성 간질환에는 간 세포내 중성지방(triglyceride)의 축적에 의한 지방간(fatty liver)과, 알콜에 의한 염증성 손상을 일으키는 알콜성 간염 (hepatitis)과, 이러한 간의만성염증으로 간조직이 섬유화조직으로 변형되는 간경변증 (liver cirrhosis) 등이 있다.In addition, alcoholic liver disease includes fatty liver due to accumulation of triglyceride in liver cells, alcoholic hepatitis causing inflammatory damage caused by alcohol, and fibrosis of liver tissue due to chronic inflammation of the liver Tissue-transformed liver cirrhosis and the like.
따라서, 현재까지 과도한 음주에 따른 숙취를 해소하기 위한 제품에 대한 연구가 다양하게 진행되어 왔으며, 그 결과 다양한 건강보조식품이 개발되고 있다. 현재까지 한국 식품의약품안전처가 '간 건강에 도움'으로 효능을 개별 인정한 원료에는 밀크씨슬 추출물, 브로콜리스프라우트 분말, 표고버섯균사체, 표고버섯균사체 추출물, 복분자 추출분말 등이 있고 '알콜성 손상으로부터 간 보호에 도움'으로 효능을 개별 인정한 원료에는 헛개나무과병 추출물, 유산균발효다시마 추출물 등이 있다. Therefore, until now, research on products for relieving hangover caused by excessive drinking has been conducted in various ways, and as a result, various health supplements have been developed. So far, the ingredients that have been individually recognized for their efficacy as 'helping liver health' by the Korean Ministry of Food and Drug Safety include milk thistle extract, broccoli prout powder, shiitake mushroom mycelium, shiitake mushroom mycelium extract, and bokbunja extract powder. Raw materials that have individually been recognized for their efficacy as 'help protect the liver' include extracts from H.
최근 상기 예시의 원료를 사용한 각종 제제 형태의 식품들이 개발되었는데 그 중 대다수는 드링크제이고 간혹 환제의 제품이 출시되고 있다. 또한, 이러한 제품들은 간기능개선 및 숙취해소 효과를 과학적으로 입증하는 데 있어 일부의 생리적 개선효과만 있거나 임상적으로 효과가 미미한 것으로 판단되고 있다. Recently, foods in the form of various formulations using the raw materials of the above examples have been developed, most of which are drinks, and sometimes pills are being marketed. In addition, these products are judged to have only some physiological improvement effects or to have insignificant clinical effects in scientifically proving the effects of improving liver function and relieving hangovers.
이에 따라, 음주로 인한 숙취증상을 해소하고 알콜성 손상으로부터 간기능을 개선하는데 도움을 줄 수 있도록 기능성을 더욱 향상시킨 식품 조성물의 개발에 대한 필요성이 높아지고 있다.Accordingly, there is a growing need for the development of a food composition with improved functionality to help relieve hangover symptoms caused by drinking and improve liver function from alcoholic damage.
본 발명은 상기와 같은 종래의 문제점을 해결하기 위한 것으로, 그 목적은 과음으로 인한 숙취증상 해소 효과를 높일 수 있고, 알콜성 간기능 저하를 효과적으로 개선할 수 있는 숙취해소 및 간기능 개선용 식품 조성물 및 이를 이용한 건강 기능식품을 제공하는데 있다. The present invention is to solve the conventional problems as described above, the purpose of which is to increase the effect of relieving hangover symptoms due to excessive drinking, and to effectively improve the alcoholic liver function deterioration food composition for hangover relief and liver function improvement And to provide a health functional food using the same.
상기의 목적을 달성하기 위하여 본 발명은, 매실농축액 30~40중량%, 양배추분말 15중량%, 토마토분말 15중량%, 밤분말 5중량%, 칡뿌리추출분말 3중량%, 다시마분말 5중량% 및 덱스트린 17~27중량%를 함유하는 숙취해소 및 간기능 개선용 식품 조성물에 특징이 있다.In order to achieve the above object, the present invention is a plum concentrate 30-40% by weight, cabbage powder 15% by weight, tomato powder 15% by weight,
또한 상기 본 발명에 있어서, 바람직하게는 매실농축액 40중량%, 덱스트린 17중량%인 숙취해소 및 간기능 개선용 식품 조성물에 특징이 있다.In addition, in the present invention, preferably, 40% by weight of plum concentrate and 17% by weight of dextrin are characterized in a food composition for relieving hangover and improving liver function.
또한 본 발명은, 상기 식품 조성물을 포함하는 건강 기능식품에 특징이 있다.In addition, the present invention is characterized by a health functional food comprising the food composition.
또한 상기 본 발명에 있어서, 건강 기능식품은 과립, 환, 정제, 캡슐 또는 음료 형태 중 어느 하나로 이루어지는 건강 기능식품에 특징이 있다.In addition, in the present invention, the health functional food is characterized in the health functional food consisting of any one of granules, pills, tablets, capsules or beverages.
상기의 특징적 구성을 가지는 본 발명의 식품 조성물 및 건강 기능식품은, 매실농축액, 양배추분말, 토마토분말, 밤분말, 칡뿌리추출분말, 다시마분말, 덱스트린 등을 함유함에 따라, 알콜섭취로 체내에 축적된 아세트알데히드를 효과적으로 분해하여 알콜농도를 현저하게 낮추고 위보호 및 속쓰림을 해소할 수 있으며, 이로써 과음으로 인한 숙취현상을 해소하고 저하된 간기능을 개선하는 효과를 상승시킬 수 있다.The food composition and health functional food of the present invention having the above characteristic composition contains plum concentrate, cabbage powder, tomato powder, chestnut powder, arrowroot extract powder, kelp powder, dextrin, etc. By effectively decomposing acetaldehyde, it is possible to significantly lower the alcohol concentration and relieve stomach protection and heartburn, thereby relieving the hangover phenomenon caused by excessive drinking and enhancing the effect of improving the deteriorated liver function.
도 1은 본 발명의 숙취해소 효능에 대한 임상실험 결과를 나타낸 그래프.
도 2는 본 발명의 간기능 개선 효능에 대한 임상실험에서 AST 수치를 나타낸 그래프.
도 3은 본 발명의 간기능 개선 효능에 대한 임상실험에서 ALT 수치를 나타낸 그래프.
도 4는 본 발명의 간기능 개선 효능에 대한 임상실험에서 γ-GTP 수치를 나타낸 그래프. 1 is a graph showing the clinical trial results for the hangover relieving efficacy of the present invention.
Figure 2 is a graph showing the AST level in a clinical trial for the liver function improvement efficacy of the present invention.
Figure 3 is a graph showing the ALT level in a clinical trial for the liver function improvement efficacy of the present invention.
Figure 4 is a graph showing the γ-GTP level in a clinical trial for the liver function improvement efficacy of the present invention.
이하, 본 발명에 따른 숙취해소 및 간기능 개선용 식품 조성물 및 이를 이용한 건강 기능식품의 바람직한 실시예를 설명한다. Hereinafter, a food composition for relieving a hangover and improving liver function according to the present invention and a preferred embodiment of a health functional food using the same will be described.
본 발명의 숙취해소 및 간기능 개선용 식품 조성물은 매실농축액, 양배추분말, 토마토분말, 밤분말, 칡뿌리추출분말, 다시마분말 및 덱스트린을 포함한다.The food composition for relieving hangover and improving liver function of the present invention includes plum concentrate, cabbage powder, tomato powder, chestnut powder, arrowroot extract powder, kelp powder and dextrin.
매실농축액은, 알콜 섭취로 인해 체내에 축적되는 에탄올(ethanol) 및 아세트알데히드(acetaldehyde)를 분해하기 위한 것으로, 물기가 마른 매실에서 씨를 발라내고 믹서로 갈아 여과포로 걸러 즙을 낸 후, 가열하여 5~6시간 조려서 수분을 증발시킴으로써 얻을 수 있고, 소화불량, 식중독, 습관성 변비, 위염, 장염, 피로회복에 효능이 있는 것으로 알려져 있다. Plum concentrate is to decompose the ethanol and acetaldehyde accumulated in the body due to alcohol intake. Remove the seeds from the dried plums, grind it with a mixer, filter it through a filter cloth to extract the juice, and heat it to 5 It can be obtained by evaporating water by boiling for ~6 hours, and it is known to be effective in indigestion, food poisoning, habitual constipation, gastritis, enteritis, and recovery from fatigue.
양배추분말은, 알콜섭취시 위를 보호하기 위한 것으로, 양배추를 채썰기하고 건조시켜 수분을 제거한 후, 분쇄하여 얻을 수 있다. 양배추분말은 천연 항궤양 식품으로 위점막을 보호하며 튼튼하게 강화해주는 성분이 있고, 위암, 대장암 같은 암예방에 효능이 있는 것으로 알려져 있으며, 또한 식이섬유가 풍부하고 열량이 낮아서 다이어트나 변비예방, 피부노화 방지에도 효능이 있다.Cabbage powder is to protect the stomach when ingesting alcohol, and can be obtained by shredding cabbage, drying it to remove moisture, and then pulverizing it. Cabbage powder is a natural anti-ulcer food with ingredients that protect and strengthen the gastric mucosa, and is known to be effective in preventing cancers such as stomach and colon cancer. It is also effective in preventing skin aging.
토마토분말은, 알콜 섭취로 인해 체내에 축적되는 에탄올(ethanol) 및 아세트알데히드(acetaldehyde)의 분해를 돕기 위한 것으로, 토마토를 잘게 썰고 건조시켜 수분을 제거한 후 분쇄하여 얻을 수 있다. 토마토에는 라이코펜 성분이 많아 항산화 효능이 우수하고 노화방지, 피부트러블 진정효과가 있으며, 또한 라이코펜 성분과 비타민C는 알콜섭취로 인해 체내에 축적된 아세트알데이드와 같은 독성물질을 배출해 주기 때문에 숙취해소에도 좋은 것으로 알려져 있다.Tomato powder is to help the decomposition of ethanol and acetaldehyde accumulated in the body due to alcohol intake, and can be obtained by slicing tomatoes, drying them, removing moisture, and then pulverizing them. Tomatoes contain a lot of lycopene, which has excellent antioxidant effects, anti-aging and soothing effects on skin problems. Also, lycopene and vitamin C release toxic substances such as acetaldehyde accumulated in the body due to alcohol intake, so it is also effective in relieving a hangover. known to be good
밤분말은, 속쓰림 해소를 위한 것으로, 밤 알갱이를 건조시켜 수분을 제거한 후, 분쇄하여 얻을 수 있다. 밤은 탄수화물, 지방, 단백질, 비타민, 무기질 등 5대 영양소를 고루 갖춘 것으로, 필수 지방산인 리놀레산이 풍부해서 몸에 해로운 중성지방과 콜레스테롤 수치를 낮추고 혈액순환을 원활하게 도와 준다. Chestnut powder, for relieving heartburn, can be obtained by drying chestnut grains to remove moisture, and then pulverizing them. Chestnuts are rich in essential fatty acids, such as linoleic acid, which contain five major nutrients, such as carbohydrates, fats, proteins, vitamins, and minerals.
또한 면역력강화, 피로회복, 숙취해소, 골다공증 예방, 뇌기능 향상등의 효능이 있고, 밤에 함유되어 있는 과당에는 위장을 튼튼하게 해주는 성분이 들어 있어 위장기능을 활발하게 하는 효능이 있다.In addition, it has effects such as strengthening immunity, recovering from fatigue, relieving hangover, preventing osteoporosis, and improving brain function.
칡뿌리추출분말은, 알콜 섭취로 인해 체내에 축적되는 에탄올(ethanol) 및 아세트알데히드(acetaldehyde)의 분해를 돕기 위한 것으로, 칡뿌리를 자연건조시켜 분쇄함으로써 얻을 수 있다. 칡뿌리추출분말은 여드름과 아토피 등 피부에 좋고, 자양강장효과가 있어 피로회복에 좋으며, 위장을 튼튼하게 해주어 소화불량이나 변비, 설사에 좋은 효능이 있다. 또한, 체내에 쌓인 중금속 배출, 골다공증 예방에 좋고, 특히 알콜 분해효소가 간을 보호하고 숙취해소에도 탁월한 효능이 있다.Arrowroot extract powder is to help the decomposition of ethanol and acetaldehyde accumulated in the body due to alcohol intake, and can be obtained by naturally drying arrowroot roots and pulverizing them. Arrowroot extract powder is good for skin such as acne and atopic dermatitis, has a nourishing and tonic effect, so it is good for fatigue recovery, and it strengthens the stomach and has good effects on indigestion, constipation, and diarrhea. In addition, it is good for excreting heavy metals accumulated in the body and preventing osteoporosis. In particular, alcohol-decomposing enzymes protect the liver and have excellent effects in relieving hangovers.
다시마분말은, 위보호를 위한 것으로, 깨끗이 손질한 다시마를 낮은 온도에서 볶은 후, 자연건조시켜 분쇄함으로써 얻을 수 있다. 다시마분말은 알긴산과 라미닌, 칼륨 등은 콜레스테롤 수치와 혈압을 낮추는 효과가 있고, 알긴산 성분은 장내의 발암물질을 배설시켜 대장암 예방 효능이 있으며, 다시마의 풍부한 요오드 성분은 갑상선 질환 예방에 좋고, 단백질, 비타민, 요오드, 철분, 칼슘 성분이 함유되어 탈모예방에 효능이 있다.Kelp powder is for stomach protection, and can be obtained by roasting cleanly trimmed kelp at a low temperature, drying it naturally and pulverizing it. Alginic acid, laminin, and potassium in kelp powder have the effect of lowering cholesterol and blood pressure, alginic acid is effective in preventing colon cancer by excreting carcinogens in the intestine. , vitamins, iodine, iron and calcium are effective in preventing hair loss.
덱스트린(dextrin)은, 전분(녹말)을 가수분해하여 얻어지는 저분자량의 탄수화물로서, 유익한 박테리아 촉진, 변비완화, 정상적인 혈당 유지, 콜레스트롤 억제 및 체중감소, 심장 건강 향상, 결장 건강 향상 등의 효능이 있다.Dextrin is a low-molecular-weight carbohydrate obtained by hydrolyzing starch (starch), and has effects such as promoting beneficial bacteria, relieving constipation, maintaining normal blood sugar, suppressing cholesterol and weight loss, improving heart health, and improving colon health. .
본 발명의 숙취해소 및 간기능 개선용 식품 조성물은, 매실농축액 30~40중량%, 양배추분말 15중량%, 토마토분말 15중량%, 밤분말 5중량%, 칡뿌리추출분말 3중량%, 다시마분말 5중량% 및 덱스트린 17~27중량%를 함유함으로써 숙취해소 및 간기능 개선효과를 향상시킬 수 있다.The food composition for relieving hangover and improving liver function of the present invention is 30-40% by weight of plum concentrate, 15% by weight of cabbage powder, 15% by weight of tomato powder, 5% by weight of chestnut powder, 3% by weight of arrowroot extract powder, kelp powder By containing 5% by weight and 17 to 27% by weight of dextrin, it is possible to improve the effect of relieving hangover and improving liver function.
바람직하게는, 상기 성분중, 매실농축액을 최대 40중량%로 함유하고, 덱스트린을 최소 17중량%로 함유시킬 경우, 음주 후 알콜농도 억제효능을 가장 높게 향상시킬 수 있다.Preferably, among the above ingredients, when the plum concentrate is contained in a maximum amount of 40% by weight and dextrin is contained in a minimum amount of 17% by weight, the alcohol concentration suppression effect after drinking can be improved the most.
또한 본 발명은, 상기의 식품 조성물을 포함시켜 과립, 환, 정제, 캡슐 또는 음료 형태 중 어느 하나로 이루어지는 건강 기능식품으로 제조할 수 있다. In addition, the present invention can be prepared as a health functional food consisting of any one of granules, pills, tablets, capsules or beverages by including the food composition.
이하, 본 발명을 실시예군 및 대조군에 의해 상세히 설명한다. 하기 실시예군 및 대조군은 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예군 및 대조군에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by means of an Example group and a control group. The following example group and control group only exemplify the present invention, and the content of the present invention is not limited by the following example group and control group.
<실시예 1><Example 1>
매실농축액 30중량%, 양배추분말 15중량%, 토마토분말 15중량%, 밤분말 5중량%, 칡뿌리추출분말 3중량%, 다시마분말 5중량% 및 덱스트린 27중량%를 혼합하여 식품 조성물을 제조한 후, 이 식품 조성물을 이용하여 환형으로 성형하는 것에 의해 실시예 1의 건강 기능식품을 제조하였다.A food composition was prepared by mixing 30% by weight of plum concentrate, 15% by weight of cabbage powder, 15% by weight of tomato powder, 5% by weight of chestnut powder, 3% by weight of arrowroot extract powder, 5% by weight of kelp powder and 27% by weight of dextrin. Then, the health functional food of Example 1 was manufactured by molding into an annular shape using this food composition.
<실시예 2><Example 2>
매실농축액 35중량%, 양배추분말 15중량%, 토마토분말 15중량%, 밤분말 5중량%, 칡뿌리추출분말 3중량%, 다시마분말 5중량% 및 덱스트린 22중량%를 혼합하여 식품 조성물을 제조한 후, 이 식품 조성물을 이용하여 환형으로 성형하는 것에 의해 실시예 2의 건강 기능식품을 제조하였다.A food composition was prepared by mixing 35% by weight of plum concentrate, 15% by weight of cabbage powder, 15% by weight of tomato powder, 5% by weight of chestnut powder, 3% by weight of arrowroot extract powder, 5% by weight of kelp powder, and 22% by weight of dextrin. Then, the health functional food of Example 2 was manufactured by molding into an annular shape using this food composition.
<실시예 3><Example 3>
매실농축액 40중량%, 양배추분말 15중량%, 토마토분말 15중량%, 밤분말 5중량%, 칡뿌리추출분말 3중량%, 다시마분말 5중량% 및 덱스트린 17중량%를 혼합하여 식품 조성물을 제조한 후, 이 식품 조성물을 이용하여 환형으로 성형하는 것에 의해 실시예 3의 건강 기능식품을 제조하였다.A food composition was prepared by mixing 40% by weight of plum concentrate, 15% by weight of cabbage powder, 15% by weight of tomato powder, 5% by weight of chestnut powder, 3% by weight of arrowroot extract powder, 5% by weight of kelp powder and 17% by weight of dextrin. Then, the health functional food of Example 3 was prepared by molding into an annular shape using this food composition.
<대조군><control group>
매실농축액 0중량%, 양배추분말 15중량%, 토마토분말 15중량%, 밤분말 5중량%, 칡뿌리추출분말 3중량%, 다시마분말 5중량% 및 덱스트린 57중량%를 혼합하여 식품 조성물을 제조한 후, 이 식품 조성물을 이용하여 환형으로 성형하는 것에 의해 대조군의 건강 기능식품을 제조하였다.A food composition was prepared by mixing 0% by weight of plum concentrate, 15% by weight of cabbage powder, 15% by weight of tomato powder, 5% by weight of chestnut powder, 3% by weight of arrowroot extract powder, 5% by weight of kelp powder and 57% by weight of dextrin. Then, a health functional food of the control group was prepared by molding into an annular shape using this food composition.
실험예 1. 체내 알콜농도 상승 억제에 대한 평가Experimental Example 1. Evaluation of the inhibition of increase in alcohol concentration in the body
나이 30~40세, 체중 65~75kg, 남성 10명을 피실험자로 하고, 알콜섭취량은 400ml(알콜도수 19.5%)로 하였다.The age of 30-40 years old, weight 65-75kg, 10 male subjects were used as test subjects, and alcohol intake was 400ml (alcohol content 19.5%).
실험은 음주 30분후에 초기 알콜농도를 측정한 후, 각 실시예 및 대조군으로 제조한 건강 기능식품 5g을 섭취시키고, 음주 90분후에 음주측정기(TNT TECH)로 알콜농도(mg/L)를 측정하였다. 실험은 각 실시예 및 대조군 별로 2주간의 간격으로 실험을 실시하였다.In the experiment, after measuring the
실험 실시기간 중에 피실험자들은 알콜섭취를 금하게 하여 실험의 정확도를 높였다. During the duration of the experiment, the subjects were prohibited from consuming alcohol to increase the accuracy of the experiment.
구분
division
알콜농도(mg/L)30 minutes after drinking
Alcohol Concentration (mg/L)
알콜농도(mg/L)90 minutes after drinking
Alcohol Concentration (mg/L)
알콜농도(mg/L)30 minutes after drinking
Alcohol Concentration (mg/L)
알콜농도(mg/L)90 minutes after drinking
Alcohol Concentration (mg/L)
구분
division
알콜농도(mg/L)30 minutes after drinking
Alcohol Concentration (mg/L)
알콜농도(mg/L)90 minutes after drinking
Alcohol Concentration (mg/L)
알콜농도(mg/L)30 minutes after drinking
Alcohol Concentration (mg/L)
알콜농도(mg/L)90 minutes after drinking
Alcohol Concentration (mg/L)
위의 표 2 및 표 3은 실험예 1에 의한 각 실시예와 대조군의 음주측정 결과를 나타낸 것이다. 표 4와 도 1에서 나타낸 음주측정 결과에 의한 알콜농도 차이를 나타낸 바와 같이, 알콜농도는 각 실시예의 경우가 대조군보다 유의적으로 낮아지는 것을 확인할 수 있다.Tables 2 and 3 above show the results of the breathalyzer measurement of each Example and the control group according to Experimental Example 1. As shown in Table 4 and the alcohol concentration difference by the results of the breathalyzer test shown in Figure 1, it can be seen that the alcohol concentration is significantly lower in the case of each Example than in the control group.
구체적으로는 대조군의 경우 음주 90분후 알콜농도가 음주 30분후 알콜농도에 비해 약 171% 상승하는 반면, 실시예 1, 실시예 2, 실시예 3은 각각 95%, 86%, 56%로 감소하였다.Specifically, in the control group, the alcohol concentration after 90 minutes of drinking increased by about 171% compared to the alcohol concentration after 30 minutes of drinking, whereas Examples 1, 2, and 3 decreased to 95%, 86%, and 56%, respectively. .
상기 결과를 통해 본 발명의 숙취해소 및 간기능 개선용 식품 조성물 및 이를 이용한 건강 기능식품을 섭취하는 경우 체내 알콜농도가 감소하는 탁월한 효과가 있음을 확인할 수 있었고, 각 실시예중에서 실시예 3이 가장 효과가 우수한 것으로 나타났다. Through the above results, it was confirmed that there is an excellent effect of reducing the alcohol concentration in the body when ingesting the food composition for relieving hangover and improving liver function of the present invention and a health functional food using the same. The effect was found to be excellent.
실험예 2. 간기능 개선에 대한 평가Experimental Example 2. Evaluation of liver function improvement
실시예 3에 의해 제조된 건강 기능식품을 간기능이 저하되어 있는 피실험자 30대 5명, 40대 5명, 50대 5명에게 1일 5g씩 아침/저녁으로 2회 30일간 섭취하도록 하였다.The health functional food prepared in Example 3 was administered to 5 subjects in their 30s, 5 people in their 40s, and 5 people in their 50s with decreased liver function, 5 g each morning/evening twice a day for 30 days.
간기능 개선의 지표는 AST(아스파테이트아미노전이효소), ALT(알라닌아미노전이효소), γ-GTP(γ-guanosine triphosphate)를 측정하여 섭취 전,후를 비교하였다.The indicators of liver function improvement were compared before and after ingestion by measuring AST (aspartate aminotransferase), ALT (alanine aminotransferase), and γ-GTP (γ-guanosine triphosphate).
AST(아스파테이트아미노전이효소) 수치의 경우, 상기 표 5와 도 2에 나타낸 바와 같이, 섭취전에는 피실험자 모두 정상범위 5~40(U/L)의 최대치보다 약 2~3배 높았으나, 섭취후에는 피실험자 모두 정상범위 내의 수치로 측정되었다.In the case of AST (aspartate aminotransferase) levels, as shown in Table 5 and FIG. 2 above, before ingestion, all subjects were about 2-3 times higher than the maximum value in the normal range of 5-40 (U/L), but after ingestion was measured as a value within the normal range for all subjects.
ALT(알라닌아미노전이효소) 수치의 경우에도 상기 표 5와 도 3에 나타낸 바와 같이, 섭취전에는 피실험자 모두 정상범위 10~40(U/L)의 최대치보다 약 2~3배 높았으나, 섭취후에는 피실험자 모두 정상범위 내의 수치로 측정되었다. Even in the case of ALT (alanine aminotransferase) levels, as shown in Table 5 and FIG. 3, before ingestion, all subjects were about 2-3 times higher than the maximum value in the normal range of 10-40 (U/L), but after ingestion, All subjects were measured to have values within the normal range.
γ-GTP(γ-guanosine triphosphate) 수치는, 상기 표 5와 도 4에 나타낸 바와 같이, 섭취전에는 피실험자 모두 정상범위 0~60(U/L)의 최대치보다 약 1.5~2배 높았으나, 섭취후에는 피실험자 모두 정상범위 내의 수치로 측정되었다.γ-GTP (γ-guanosine triphosphate) levels, as shown in Table 5 and Figure 4, before ingestion, all subjects were about 1.5 to 2 times higher than the maximum value of the normal range 0-60 (U/L), but after ingestion was measured as a value within the normal range for all subjects.
상기 결과를 통해, 본 발명의 숙취해소 및 간기능 개선용 식품 조성물 및 이를 이용한 건강 기능식품을 섭취하는 경우 저하된 간기능을 유의적으로 개선할 수 있음을 알 수 있었다. Through the above results, it was found that when the food composition for relieving hangover and improving liver function of the present invention and a health functional food using the same are consumed, the decreased liver function can be significantly improved.
지금까지 본 발명은, 실시예들이 비록 한정된 실시예와 도면에 의해 설명되었으나, 해당 기술분야에서 통상의 지식을 가진 자라면 상기의 기재로부터 다양한 수정 및 변형이 가능하다. 예를 들어, 설명된 기술들이 설명된 방법과 다른 순서로 수행되거나, 및/또는 설명된 구성요소들이 설명된 방법과 다른 형태로 결합 또는 조합되거나, 다른 구성요소 또는 균등물에 의하여 대치되거나 치환되더라도 적절한 결과가 달성될 수 있다.Although the embodiments of the present invention have been described by way of limited examples and drawings, various modifications and variations are possible from the above description by those skilled in the art. For example, even if the described techniques are performed in an order different from the described method, and/or the described components are combined or combined in a different form from the described method, or are substituted or substituted by other components or equivalents Appropriate results can be achieved.
그러므로, 다른 구현들, 다른 실시예들 및 청구범위와 균등한 것들도 후술하는 청구범위의 범위에 속한다.Therefore, other implementations, other embodiments, and equivalents to the claims are also within the scope of the following claims.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200168648A KR102367717B1 (en) | 2020-12-04 | 2020-12-04 | Food composition for relieving hangovers and improving a liver and food containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200168648A KR102367717B1 (en) | 2020-12-04 | 2020-12-04 | Food composition for relieving hangovers and improving a liver and food containing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102367717B1 true KR102367717B1 (en) | 2022-02-25 |
Family
ID=80490379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200168648A KR102367717B1 (en) | 2020-12-04 | 2020-12-04 | Food composition for relieving hangovers and improving a liver and food containing the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102367717B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR950024764A (en) * | 1994-02-18 | 1995-09-15 | 강상모 | Alcoholic Disorder Protectors And How To Use Him |
KR101588378B1 (en) * | 2015-08-12 | 2016-01-25 | (주)포원텍 | Method for manufacturing hangover curing agent and hangover curing agent manufactured by the same |
-
2020
- 2020-12-04 KR KR1020200168648A patent/KR102367717B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR950024764A (en) * | 1994-02-18 | 1995-09-15 | 강상모 | Alcoholic Disorder Protectors And How To Use Him |
KR101588378B1 (en) * | 2015-08-12 | 2016-01-25 | (주)포원텍 | Method for manufacturing hangover curing agent and hangover curing agent manufactured by the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101776071B1 (en) | Composition containing red sword bean extract for anti-aging and whitening | |
KR20200120465A (en) | Composition for preventing or treating liver damage by alcohol which is excellent in hangover resolution | |
CN111374297A (en) | Compound salt and preparation method thereof | |
KR20200062654A (en) | Composition for relieving hangover or improving liver function containing lactobacillus helveticus | |
CN106858215A (en) | A kind of passion fruit composite beverage | |
CN105918387A (en) | Healthcare food suitable for middle aged and elderly people and preparation method thereof | |
KR101217080B1 (en) | Composition having herb extract as active incredient for treating hangover and preparation method thereof | |
JP2004091464A (en) | Obesity inhibitor | |
KR20210063657A (en) | A natural tea removing the effect of hangover contained the extract material in Hovenia dulcis and a cactus | |
CN104667135A (en) | Pharmaceutical composition and health care product and preparation method | |
EP3854226A1 (en) | Method for fractionating olive pomace, its products and uses thereof | |
KR101643385B1 (en) | Method for preparing pills with aronia and pills by the method | |
KR20060117550A (en) | Composition for curing a hangover and preparation method thereof | |
KR102197395B1 (en) | The process of making healthcare composition for relieving and preventing alcoholic hangover comprising fermented Dendropanax morbifera extract and Capsosiphon fulvescens extracts | |
KR102127411B1 (en) | Composition comprising natural complex extract for protecting liver and relieving hangover | |
KR102367717B1 (en) | Food composition for relieving hangovers and improving a liver and food containing the same | |
KR101045279B1 (en) | Composition of functional food with weight loss effect | |
KR102457306B1 (en) | Health function food composition comprising lactobacillus for improving skin and vowel function and method of preparing the same | |
KR101958969B1 (en) | A composition for improving, preventing and treating of alcoholic gastrointestinal diseases comprising a complex extract of seaweed and complex extract of plant | |
KR20170086198A (en) | Manufacturing method of diet solid tea including fermentation herb remedy and dietary fiber and the solid tea produced thereby | |
KR101113603B1 (en) | Extract composition of herbal mixture for improving liver fucntion and relieving hangover | |
KR20090081062A (en) | A diabetes pharmaceutical composition and manufacturing process thereof | |
KR102433586B1 (en) | Food composition for relieving hangover and improving hepatic function | |
KR102238009B1 (en) | Red ginseng products containing noni and the process for the preparation thereof | |
CN1426810A (en) | Anti alcoholic agent using alder as material and mfg. method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |